TY  - GEN
AU  - de Galan,B E
AU  - Zoungas,S
AU  - Chalmers,J
AU  - Anderson,C
AU  - Dufouil,C
AU  - Pillai,A
AU  - Cooper,M
AU  - Grobbee,D E
AU  - Hackett,M
AU  - Hamet,P
AU  - Heller,S R
AU  - Lisheng,L
AU  - MacMahon,S
AU  - Mancia,G
AU  - Neal,B
AU  - Pan,C Y
AU  - Patel,A
AU  - Poulter,N
AU  - Travert,F
AU  - Woodward,M
TI  - Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial
SN  - 1432-0428
PY  - 2010///0426
KW  - Aged
KW  - Antihypertensive Agents
KW  - therapeutic use
KW  - Cognition
KW  - drug effects
KW  - Cognition Disorders
KW  - complications
KW  - Diabetes Mellitus, Type 2
KW  - blood
KW  - Diabetic Angiopathies
KW  - epidemiology
KW  - Drug Combinations
KW  - Drug Therapy, Combination
KW  - Educational Status
KW  - Female
KW  - Gliclazide
KW  - Humans
KW  - Hypoglycemia
KW  - Hypoglycemic Agents
KW  - Indapamide
KW  - Male
KW  - Mental Status Schedule
KW  - Myocardial Infarction
KW  - Perindopril
KW  - Risk Factors
KW  - Stroke
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s00125-009-1484-7
ER  -